Canada Spends Logo

Explore our Budget 2026 analysis

Grant: Discovery Grants Program - Individual

University of Toronto

$27,000.00

Mitochondrial RNA polymerase in the nucleus

FY 2010-11

Summary
In textbooks nuclear mRNA transcription is the sole domain of RNA polymerase II. Recently however, a new RNA polymerase, spRNAP-IV, was discovered that transcribes several hundred nuclear genes and is required for cell survival. Both RNA polymerase II and spRNAP-IV synthesize mRNA in mammalian cells. Bizarrely, spRNAP-IV is a truncated version of the mitochondrial RNA polymerase. spRNAP-IV is an alternatively spliced product from the nuclear gene encoding the mitochondrial RNA polymerase, POLRMT. spRNAP-IV lacks the mitochondrial localization signal and functions in the nucleus. Surprisingly, the fundamental biological importance of spRNAP-IV remains unappreciated and completely uninvestigated in the four years since its initial discovery. We are now proposing a series of studies that examine the relationship between the RNA polymerase spRNAP-IV and DNA damage. Using cell and molecular biology approaches, we will determine whether inhibiting spRNAP-IV increases cell sensitivity to DNA damage and we will assess the fidelity of spRNAP-IV transcription when the polymerase encounters DNA damage. This fourth new mammalian nuclear RNA polymerase, spRNAP-IV adds a new and important dimension to mammalian mRNA transcription in the face of DNA damage.
Program
Discovery Grants Program - Individual
Location
Ontario, Canada
Recipient Type
Academia
Type
Grant
Source
NSERC's Awards Data

As published

Application id
371521-2010
Name nom
Laposa, Rebecca
Department département
Pharmacology and Toxicology
Organization id
31
Institution établissement
University of Toronto
Province en
Ontario
Province fr
Ontario
Country en
CANADA
Country fr
CANADA
Fiscal year exercice financier
2010
Competition year année de concours
2010
Award amount
27000
Program id
RGPIN
Program name en
Discovery Grants Program - Individual
Program name fr
Programme de subventions à la découverte - individuelles
Group en
Discovery grants programs
Group fr
Programmes de subventions à la découverte
Committee code
1501
Committee name en
Genes, Cells and Molecules
Committee name fr
Gènes, cellules et molécules
Area of application code
1201
Area of application group en
Advancement of knowledge
Area of application group fr
Avancement des connaissances
Area of application en
Life sciences (including biotechnology)
Area of application fr
Sciences de la vie (y compris biotechnologie)
Research subject code
5302
Research subject group en
Molecular biology
Research subject group fr
Biologie moléculaire
Research subject en
Gene expression
Research subject fr
Expression génétique
Partie
1
Nb partie
5
Application title
Mitochondrial RNA polymerase in the nucleus
Keyword
NSERC
Application summary
In textbooks nuclear mRNA transcription is the sole domain of RNA polymerase II. Recently however, a new RNA polymerase, spRNAP-IV, was discovered that transcribes several hundred nuclear genes and is required for cell survival. Both RNA polymerase II and spRNAP-IV synthesize mRNA in mammalian cells. Bizarrely, spRNAP-IV is a truncated version of the mitochondrial RNA polymerase. spRNAP-IV is an alternatively spliced product from the nuclear gene encoding the mitochondrial RNA polymerase, POLRMT. spRNAP-IV lacks the mitochondrial localization signal and functions in the nucleus. Surprisingly, the fundamental biological importance of spRNAP-IV remains unappreciated and completely uninvestigated in the four years since its initial discovery. We are now proposing a series of studies that examine the relationship between the RNA polymerase spRNAP-IV and DNA damage. Using cell and molecular biology approaches, we will determine whether inhibiting spRNAP-IV increases cell sensitivity to DNA damage and we will assess the fidelity of spRNAP-IV transcription when the polymerase encounters DNA damage. This fourth new mammalian nuclear RNA polymerase, spRNAP-IV adds a new and important dimension to mammalian mRNA transcription in the face of DNA damage.